EUCTR2015-004442-25-Outside-EU/EEA进行中（未招募）不适用
A multicenter, open-label, single-arm, two-step study to evaluate the safety and single-dose pharmacokinetics of famciclovir and multiple-dose safety after administration of famciclovir oral pediatric formulation to children 1 to 12 years of age with varicella zoster infection
ovartis Pharmaceuticals0 个研究点目标入组 76 人开始时间: 2016年4月12日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female children 1-12 years of age
- •Clinical or laboratory evidence of varicella zoster infection
- •Patients suspected of having varicella zoster infection
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 76
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients unable to swallow
- •Concomitant use of probenecid
- •Positive pregnancy
研究者
相似试验
进行中（未招募）
不适用
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex InfectioHerpes SimplexEUCTR2015-004441-17-Outside-EU/EEAovartis Pharmaceuticals74
进行中（未招募）
1 期
A multicenter, open-label, single-arm, two-stage study of the efficacy and safety of AVE0005 (VEGF Trap) administered intravenously every 2 weeks in patients with platinum- and erlotinib-resistant, locally advanced or metastatic non-small-cell lung adenocarcinoma.patients with platinum- and erlotinib-resistant, locally advanced or metastatic non-small-cell lung adenocarcinoma.EUCTR2006-006144-55-FRsanofi-aventis recherche & développement94
进行中（未招募）
1 期
A single arm, open-label, phase II, multicentre study to assess the safety of vismodegib (GDC-0449) in patients with locally advanced or metastatic basal cell carcinoma (BCC).EUCTR2011-000195-34-ITROCHE501
进行中（未招募）
1 期
A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell CarcinomaEUCTR2011-000195-34-NLF. Hoffmann-La Roche Ltd.1,200
进行中（未招募）
1 期
A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell CarcinomaEUCTR2011-000195-34-GBF. Hoffmann-La Roche Ltd.501